Chargement…
Médicaments publiés par l'ARP : médicament, DCI, dosage, forme galénique, voie d'administration, laboratoire et classe thérapeutique.
7 458 enregistrements · affichage 5 676–5 700
| NOM DU MEDICAMENT | DCI | dosage | présentation | Forme Galénique | Voie d'administration | Laboratoire | classe thérapeutique |
|---|
3a3a5d10b20f…Empreinte d'intégrité du fichier source, publique et sans valeur de secret.| CO-VEPRAN | IRBESARTAN/HYDROCHLOROTHIAZIDE | 150mg/12,5mg | B/28 | comprime | orale | SOTHEMA | |
| CO-VEPRAN | HYDROCHLOROTHIAZIDE/IRBESARTAN | 25 mg / 300 mg | B/28 | comprimé | orale | WEST AFRIC PHARMA | Anti hypertenseur |
| CO-VEPRAN | IRBESARTAN/HYDROCHLOROTHIAZIDE | 300mg/25mg | B/28 | comprime | orale | SOTHEMA | |
| CO-VEPRAM | HYDROCHLOROTHIAZIDE/IRBESARTAN | 12.5 mg / 150 mg | B/28 | comprimé | orale | WEST AFRIC PHARMA | ANTIHYPERTENSEUR |
| CO-VALSARTAN WIN | HYDROCHOROTHIAZIDE/VALSARTAN | 160 mg / 25 mg | B/28 | comprimé pelliculé | orale | MAPHAR | ANTIHYPERTENSEUR |
| CO-VALSARTAN WIN | HYDROCHOROTHIAZIDE/VALSARTAN | 160 mg / 25 mg | B/28 | comprimé pelliculé | orale | MAPHAR | ANTIHYPERTENSEUR |
| CO-TRIMOXAZOLE ECOBI | SULFAMETHOXAZOLE/TRIMETHOPRIME | 200 mg / 40 mg | FL/100ml | suspension buvable | orale | ECOBI FARMACEUTICI | ANTIBIOTIQUE |
| CO-TRIMOXAZOLE ECOBI | SULFAMETHOXAZOLE/TRIMETHOPRIME | 400 mg / 80 mg | B/20 | comprimé | orale | ECOBI FARMACEUTICI | ANTIBIOTIQUE |
| CO-TRIMOXAZOLE | SULFAMETHOXAZOLE/TRIMETHOPRIME | 400 mg / 80 mg | B/10 | comprimé | orale | STERING LAB | ANTIBIOTIQUE |
| CO-TRIM FORT | SULFAMETHOXAZOLE/TRIMETHOPRIME | 0.800 g / 1.60 g | B/20 | comprimé | orale | LAPROPHAN | ANTIBIOTIQUE |
| CO-TRIM | SULFAMETHOXAZOLE/TRIMETHOPRIME | 400 mg / 80 mg | FL/100ml | suspension buvable | orale | LAPROPHAN | ANTIBIOTIQUE |
| CO-THERAPRIL | PERINDOPRIL/AMLODIPINE | 10 mg / 5mg | B/30 | comprime | orale | THERA | INHIBITEUR DE L’ENZYME DE CONVERSION ( IEC ) ET INHIBITEUR C ALCIQUE |
| CO-THERAPRIL | PERINDOPRIL/AMLODIPINE | 10 mg / 10 mg | B/30 | comprime | orale | THERA | INHIBITEURS DE L’ENZYME DE CONVERSION (IEC) ET INHIBITEURS CALCIQUES |
| CO-THERAPRIL | PERINDOPRIL/AMLODIPINE | 5 mg / 5 mg | B/30 | comprime | orale | THERA | INHIBITEUR DE L’ENZYME DE CONVERSION ( IEC ) ET INHIBITEUR C ALCIQUE |
| CO-TECPRIL | RAMIPRIL/HYDROCHLOROTHIAZIDE | 5 mg / 12,5 mg | B/30 | gellule | orale | AFRICPHARM | Hypertension artérielle |
| CO-TAREG | VALSARTAN/HYDROCHLOTHIAZIDE | ???? | B/28 | comprimé | orale | NOVARTIS PHARMA | ASSOCIATION ANTIHYPERTENSEUR |
| CO-TAREG | HYDROCHLOROTHIAZIDE/VALSARTAN | 160 mg / 25 mg | B/28 | comprimé | orale | NOVARTIS PHARMA | ANTIHYPERTENSEUR |
| CO-OLMETEC | QUINAPRIL/HYDROCHLOROTHIAZIDE | 40 mg/25 mg | B/30 | comprimé | orale | RANBAXY | antihypertenseurs |
| CO-OLMETEC | HYDROCHLORTHIAZIDE/OLMESARTAN | 20 mg / 25 mg | B/30 | comprimé | orale | SANKYO PHARMA GMBH | ANTIHYPERTENSEUR |
| CO-LOSARMEDIS | HYDROCHLOROTHIAZIDE/LOSARTAN | 12,5 mg / 50 mg | B/30 | comprimé pelliculé | orale | MEDIS | ANTIHYPERTENSEUR |
| CO-LOSAR PLUS | LOSARTAN POTASSIQUE/HYDRCHLOROTHIAZIDE | 100 mg / 12,5 mg | B/30 | comprime pellicule | orale | MEDIS | |
| CO-LOSAR | LOSARTAN POTASSIQUE/HYDRCHLOROTHIAZIDE | 50 mg / 12,5 mg | B/30 | comprime pellicule | orale | MEDIS | |
| CO-DOPCOR | HYDROCHLOROTHIAZIDE/VALSARTAN | 12,5 mg / 80 mg | B/30 | comprimé pelliculé | orale | ASPEN PHARMACARE | ANTIHYPERTENSEUR |
| CO-DOPCOR | HYDROCHLOROTHIAZIDE/VALSARTAN | 160 mg / 25 mg | B/30 | comprimé pelliculé | orale | ASPEN PHARMACARE | ANTIHYPERTENSEUR |
| CO-AVAZIR | DEXAMETHAZONE / TOBRAMYCINE | 0,1 % / 0,3 % | FL/5ml | collyre | oculaire | ORCHIDIA | ANTIBIOTIQUE |
CO-VEPRAN
CO-VEPRAN
CO-VEPRAN
CO-VEPRAM
CO-VALSARTAN WIN
CO-VALSARTAN WIN
CO-TRIMOXAZOLE ECOBI
CO-TRIMOXAZOLE ECOBI
CO-TRIMOXAZOLE
CO-TRIM FORT
CO-TRIM
CO-THERAPRIL
CO-THERAPRIL
CO-THERAPRIL
CO-TECPRIL
CO-TAREG
CO-TAREG
CO-OLMETEC
CO-OLMETEC
CO-LOSARMEDIS
CO-LOSAR PLUS
CO-LOSAR
CO-DOPCOR
CO-DOPCOR
CO-AVAZIR